UTRGV International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover)
UTRGV 健康差异国际会议:阿片类药物和酒精使用障碍及相关合并症的治疗和康复 (ICHD-Recover)
基本信息
- 批准号:10649618
- 负责人:
- 金额:$ 3.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAccelerationAddressAffectAlcoholsAreaAwardAwarenessBorder CommunityCOVID-19 pandemicClinicCollaborationsCommunitiesCommunity HealthCommunity Health AidesCommunity OutreachCommunity ServicesDisadvantagedDisadvantaged minorityDisciplineDiseaseEducationFacultyFamilyFosteringFundingGrantHealthHealth Disparities ResearchHealth PersonnelHealth PolicyHealth ServicesHealth StatusHealthcareHispanicHispanic PopulationsHispanic-serving InstitutionIndividualInstitutionInternal MedicineInternationalInterventionKnowledgeLatin AmericaLife StyleMedical ResearchMedical StudentsMexicanMexicoMinority GroupsMissionOpioidParticipantPersonal SatisfactionPersonsPhysiciansPoaceaePolicy MakerPostdoctoral FellowProcessPsychiatryPublic HealthRecoveryReportingRequest for ApplicationsResearchResearch PersonnelResearch SupportScienceScientific Advances and AccomplishmentsScientistSouth TexasStudentsSubstance Use DisorderSubstance abuse problemTechnology TransferTexasTranslationsTravelUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWomanalcohol misusealcohol use disorderbilingualismcommunity buildingcommunity engaged researchcommunity engagementcommunity interventioncomorbiditydesignethnic minorityglobal healthhealth determinantshealth disparityhealth organizationimplementation scienceinnovationintervention programmedical schoolsminority healthminority health disparitymultimodalitynovel strategiesopioid misuseopioid useopioid use disorderoverdose deathposterspre-doctoralprogramssocialsocial determinantssocial health determinantssubstance usesymposiumtreatment disparityunderserved minority
项目摘要
ABSTRACT
The University of Texas Rio Grande Valley (UTRGV), the second largest Hispanic-serving institution in the
nation, founded the School of Medicine (SOM) in 2015 to address the health needs of the underrepresented
minority (URM) populations of south Texas on the US-Mexico border. In 2017, as part of its mission, the SOM
began hosting an annual research conference on health disparities. The conference was the first of its kind in
the Rio Grande Valley (RGV). To date, more than half the participants have been URMs and women. Each year
since 2017 UTRGV has held a health disparities research conference that has attracted more than 300 attendees
each year. With expected participation from both US and Mexico border institutions, the UTRGV-SOM will host
the 5th and 6th conferences on September 9-10, 2022, and September 8-9, 2023. The title will be “International
Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related
Comorbidities (ICHD-Recover).” Opioid and alcohol use disorders are significant national public health problems
and are particularly severe among URM populations. The ICHD-Recover has the following Specific Aims: 1) To
accelerate collaborations among researchers at the national level and across the U.S.-Mexico border, 2) To
facilitate engagement and collaboration with community stakeholders in research and implementation of
culturally relevant interventions, thus obtaining community support for research on substance use disorders, 3)
To stimulate new lines of research addressing URM health with a focus on opioid and alcohol use disorders and
related comorbidities, 4) To motivate trainees from URM populations to engage in substance abuse research,
and 5) To disseminate research findings from the Rio Grande Valley (RGV) to researchers and health policy
makers in other border regions and states and the nation. The proposed conferences will include nationally
known speakers, plenary sessions, abstracts, and posters presented by students, researchers, fellows, faculty,
and professionals from the U.S. and neighboring Mexican border institutions. Seventy five percent of our
speakers are from URM. Funds will be used to 1) invite leading researchers, health disparity experts and young
scientists, from the U.S. border regions and Mexico, and 2) implement the proposed scientific agenda over two
days, thus showcasing community-engaged research in which researchers and practitioners address opioid and
alcohol use disorder health disparities in URM populations. The ICHD-Recover closely aligns with the NIH
mission, which is to support global opioid and alcohol use disorders and health disparities research to advance
scientific knowledge and aid all those affected to recover from the consequences of opioid and alcohol misuse.
The ICHD-Recover conferences will, 1) emphasize how the medical research community can most effectively
interact with community stakeholders, considering the social determinants of health to inform the design and
implementation of community intervention programs, and 2) address health disparities in persons suffering from
the consequences of opioid and alcohol misuse and associated comorbidities in URM populations.
摘要
德克萨斯大学格兰德河谷分校(UTRGV)是美国第二大西班牙裔服务机构,
2015年成立了医学院(SOM),以解决代表性不足的健康需求
少数民族(URM)人口的南得克萨斯州的美国-墨西哥边境。2017年,作为其使命的一部分,
开始主持一个关于健康差距的年度研究会议。这次会议是年的第一次此类会议。
格兰德河流域。到目前为止,一半以上的参与者是城市管理机构和妇女。每年
自2017年以来,UTRGV举办了一次健康差异研究会议,吸引了300多名与会者
每年.在美国和墨西哥边境机构的预期参与下,UTRGV-SOM将主办
第五届和第六届会议将于2022年9月9日至10日和2023年9月8日至9日举行。标题将是“国际
健康差距会议:阿片类和酒精使用障碍及相关疾病的治疗和康复
合并症(ICHD-Recover)。阿片类药物和酒精使用障碍是重要的国家公共卫生问题
在URM人群中尤为严重。ICHD-Recover有以下具体目标:
加速国家一级和美国各地研究人员之间的合作-墨西哥边境,2)到
促进与社区利益相关者的参与和合作,
文化上相关的干预措施,从而获得社区对药物使用障碍研究的支持,3)
刺激针对URM健康的新研究路线,重点关注阿片类药物和酒精使用障碍,
4)激励来自URM人群的学员参与药物滥用研究,
和5)向研究人员和卫生政策传播格兰德河流域的研究成果
其他边境地区和国家的制造商。拟议的会议将包括国家一级的会议。
已知的发言人,全体会议,摘要和海报提出的学生,研究人员,研究员,教师,
以及来自美国和邻近墨西哥边境机构的专业人士。我们75%的
演讲者来自URM。资金将用于1)邀请领先的研究人员,健康差距专家和年轻人
科学家,从美国边境地区和墨西哥,和2)实施拟议的科学议程超过两个
天,从而展示了社区参与的研究,其中研究人员和从业人员解决阿片类药物和
URM人群中酒精使用障碍的健康差异。ICHD-Recover与NIH密切相关
使命,即支持全球阿片类药物和酒精使用障碍和健康差异研究,以推进
科学知识,并帮助所有受影响的人从阿片类药物和酒精滥用的后果中恢复过来。
ICHD-Recover会议将:1)强调医学研究界如何最有效地
与社区利益相关者互动,考虑健康的社会决定因素,为设计提供信息,
实施社区干预方案,2)解决患有
阿片类药物和酒精滥用的后果以及URM人群中的相关合并症。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IHSAN M SALLOUM其他文献
IHSAN M SALLOUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IHSAN M SALLOUM', 18)}}的其他基金
UTRGV International Conference on Health Disparities: Treatment and Recovery from Opioid and Alcohol Use Disorders and Related Comorbidities (ICHD-Recover)
UTRGV 健康差异国际会议:阿片类药物和酒精使用障碍及相关合并症的治疗和康复 (ICHD-Recover)
- 批准号:
10469128 - 财政年份:2022
- 资助金额:
$ 3.1万 - 项目类别:
Stem Cell Therapy, Inflammation and Treatement Response in Alcholoism-Depression Comobidity
酒精中毒-抑郁症合并症的干细胞治疗、炎症和治疗反应
- 批准号:
10252067 - 财政年份:2020
- 资助金额:
$ 3.1万 - 项目类别:
Stem Cell Therapy, Inflammation and Treatement Response in Alcholoism-Depression Comobidity
酒精中毒-抑郁症合并症的干细胞治疗、炎症和治疗反应
- 批准号:
10187777 - 财政年份:2020
- 资助金额:
$ 3.1万 - 项目类别:
Valproate Efficacy in Cocaine-Bipolar Comorbidity
丙戊酸治疗可卡因双相情感障碍的疗效
- 批准号:
7640768 - 财政年份:2005
- 资助金额:
$ 3.1万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 3.1万 - 项目类别:
Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Standard Grant














{{item.name}}会员




